CooperCompanies Announces Release Date for Third Quarter 2026
Rhea-AI Summary
CooperCompanies (Nasdaq: COO) announced it will release its third quarter 2026 financial results on Wednesday, September 9, 2026, at 4:15 PM ET. The company will then host a conference call at 5:00 PM ET to discuss the results and current corporate developments, with an audio webcast and replay available at its investor relations website.
Positive
- None.
Negative
- None.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jul 01 | social partnership | Positive | +3.1% | Announced support for Saving Mothers and global women’s health initiatives. |
| Jun 30 | sustainability report | Positive | +0.3% | Disclosed Scope 3 emissions and alignment with SASB and TCFD recommendations. |
| Jun 04 | Q2 earnings | Positive | +8.6% | Reported Q2 growth, non-GAAP EPS expansion, and updated fiscal 2026 guidance. |
| May 29 | leadership appointment | Positive | +0.3% | Appointed Muru Annamalai as President, Asia-Pacific, effective June 1, 2026. |
| May 04 | board appointment | Positive | -0.4% | Appointed Paul Keel independent director and Audit Committee member effective July 1. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Four of five recent news events aligned with positive 24-hour reactions; one board appointment diverged with a negative reaction.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN RAMON, Calif., July 30, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today it will report third quarter 2026 financial results on Wednesday, September 9, 2026, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments.
The dial-in number for the call is 800-715-9871 and the conference ID is 9708839. A simultaneous audio webcast and subsequent replay can be accessed at www.investor.coopercos.com
About CooperCompanies
CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on helping people experience life’s beautiful moments through its two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, helping to improve the way people see each day. CooperSurgical is a leading fertility and women’s healthcare company dedicated to putting time on the side of women, babies, and families at the healthcare moments that matter most. Headquartered in San Ramon, CA, CooperCompanies has a workforce of more than 15,000, sells products in over 130 countries, and positively impacts over fifty million lives each year. For more information, please visit www.coopercos.com
Contact:
Kim Duncan
Vice President, Investor Relations and Risk Management
925-460-3663
ir@cooperco.com
